Maine's drug import law puts pharma's reputation at risk, PhRMA says

10/27/2013 | FDAnews

More lawsuits could be filed against the pharmaceutical industry with the implementation of Maine's law that authorizes the direct purchase of mail-order drugs from certain foreign pharmacies. "It's our reputation that's going to be at stake, not CanaRx," said Mit Spears, executive vice president and general counsel of the Pharmaceutical Research and Manufacturers of America. The Maine law undermines the push in the U.S. for a drug track-and-trace system and could lead to similar moves in other states, Spears said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Senior Marketing Manager - Media
Shoe Carnival, Inc.
Evansville, Indiana
Ralph Lauren
New York, New York
Sr. Financial Analyst
Orchard Brands
Beverly, Massachusetts
Customer Insights Manager
The Exchange
AAFES HQ, Dallas, Texas
Branch Manager
Crescent Electric Supply Company
Fort Dodge, IA